Viewing Study NCT06987695

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:12 PM
Ignite Modification Date: 2026-02-07 @ 3:26 PM
Study NCT ID: NCT06987695
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-05-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease
Sponsor: Amgen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Obesity Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Overweight View
None BMI View
None Body weight View
None Maridebart cafraglutide View
None Chronic weight management View
None MariTide View
None Type 2 Diabetes Mellitus View
None T2DM View